284 related articles for article (PubMed ID: 24622265)
1. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study.
Gidlöf S; Falhammar H; Thilén A; von Döbeln U; Ritzén M; Wedell A; Nordenström A
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):35-42. PubMed ID: 24622265
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden.
Strandqvist A; Falhammar H; Lichtenstein P; Hirschberg AL; Wedell A; Norrby C; Nordenskjöld A; Frisén L; Nordenström A
J Clin Endocrinol Metab; 2014 Apr; 99(4):1425-32. PubMed ID: 24476073
[TBL] [Abstract][Full Text] [Related]
3. Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: A total population study.
Engberg H; Butwicka A; Nordenström A; Hirschberg AL; Falhammar H; Lichtenstein P; Nordenskjöld A; Frisén L; Landén M
Psychoneuroendocrinology; 2015 Oct; 60():195-205. PubMed ID: 26184920
[TBL] [Abstract][Full Text] [Related]
4. Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study.
Falhammar H; Frisén L; Hirschberg AL; Norrby C; Almqvist C; Nordenskjöld A; Nordenström A
J Clin Endocrinol Metab; 2015 Sep; 100(9):3520-8. PubMed ID: 26126207
[TBL] [Abstract][Full Text] [Related]
5. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.
Gidlöf S; Wedell A; Guthenberg C; von Döbeln U; Nordenström A
JAMA Pediatr; 2014 Jun; 168(6):567-74. PubMed ID: 24733564
[TBL] [Abstract][Full Text] [Related]
6. Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H; Butwicka A; Landén M; Lichtenstein P; Nordenskjöld A; Nordenström A; Frisén L
J Clin Endocrinol Metab; 2014 Mar; 99(3):E554-60. PubMed ID: 24302749
[TBL] [Abstract][Full Text] [Related]
7. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
Thil'en A; Nordenström A; Hagenfeldt L; von Döbeln U; Guthenberg C; Larsson A
Pediatrics; 1998 Apr; 101(4):E11. PubMed ID: 9521977
[TBL] [Abstract][Full Text] [Related]
8. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Falhammar H; Frisén L; Norrby C; Hirschberg AL; Almqvist C; Nordenskjöld A; Nordenström A
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2715-21. PubMed ID: 25279502
[TBL] [Abstract][Full Text] [Related]
9. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
10. Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study.
Nordenström A; Svensson J; Lajic S; Frisén L; Nordenskjöld A; Norrby C; Almqvist C; Falhammar H
J Clin Endocrinol Metab; 2019 Dec; 104(12):6148-6154. PubMed ID: 31393570
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase.
Speiser PW; Agdere L; Ueshiba H; White PC; New MI
N Engl J Med; 1991 Jan; 324(3):145-9. PubMed ID: 1984191
[TBL] [Abstract][Full Text] [Related]
12. Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening.
Nordenström A; Ahmed S; Jones J; Coleman M; Price DA; Clayton PE; Hall CM
Horm Res; 2005; 63(1):22-8. PubMed ID: 15627780
[TBL] [Abstract][Full Text] [Related]
13. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(4):247-51. PubMed ID: 19786796
[TBL] [Abstract][Full Text] [Related]
14. Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood.
White PC; Bachega TA
Semin Reprod Med; 2012 Oct; 30(5):400-9. PubMed ID: 23044877
[TBL] [Abstract][Full Text] [Related]
15. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Hagenfeldt K; Janson PO; Holmdahl G; Falhammar H; Filipsson H; Frisén L; Thorén M; Nordenskjöld A
Hum Reprod; 2008 Jul; 23(7):1607-13. PubMed ID: 18420648
[TBL] [Abstract][Full Text] [Related]
16. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(5):310-4. PubMed ID: 19844117
[TBL] [Abstract][Full Text] [Related]
17. Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study.
Falhammar H; Frisén L; Hirschberg AL; Nordenskjöld A; Almqvist C; Nordenström A
J Clin Endocrinol Metab; 2022 Jan; 107(2):e475-e486. PubMed ID: 34601607
[TBL] [Abstract][Full Text] [Related]
18. Reduced Frequency of Biological and Increased Frequency of Adopted Children in Males With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study.
Falhammar H; Frisén L; Norrby C; Almqvist C; Hirschberg AL; Nordenskjöld A; Nordenström A
J Clin Endocrinol Metab; 2017 Nov; 102(11):4191-4199. PubMed ID: 28945916
[TBL] [Abstract][Full Text] [Related]
19. [Congenital adrenal hyperplasia: clinical aspects and neonatal screening].
Stikkelbroeck MM; Otten BJ
Ned Tijdschr Geneeskd; 2002 Feb; 146(6):246-9. PubMed ID: 11865652
[TBL] [Abstract][Full Text] [Related]
20. [Congenital adrenal hyperplasia].
Bouvattier C; Chatelain P
Rev Prat; 2008 May; 58(9):990-4. PubMed ID: 18672665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]